A major advance in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This vital malignant suppressor protein is frequently disabled in several kinds of malignancies, leading https://madbookmarks.com/story21989567/vhh-fragments-restore-the-p53-protein-new-new-pathway-for-malignant-management